Wednesday, May 22, 2013

Celebrating the status quo at the University of Minnesota

If the University of Minnesota has felt any pressure to reform the way it oversees clinical research, it is certainly not betraying any evidence of it. From the gala send-off for the General Counsel, through the aggressive public statements of the Dean of the Medical School and the relentless public relations campaign for Charles Schulz, it has become plain that no plans for change are being contemplated. Just the opposite, in fact: the President of the university has made it clear that he wants more clinical trials and more partnerships with industry.

Given our scandal-plagued history, this is not really a surprise. Perhaps the petition calling for an investigation will eventually have an effect. In the meantime, however, the very same rules and oversight system that failed Dan Markingson will continue to fail other vulnerable patients.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.